Best Private Equity Funds Companies in China

China's Private Equity Funds market is bigger than most outsiders assume, and our directory of 609 tracked companies, carrying $385M in total disclosed funding, is the most current ranking you'll find sorted by equity raised and recent momentum. AMTD accounts for the full $385M in disclosed capital, which tells you something real about how concentrated the top of this market actually is. Most firms here, including 3E BioVentures, 3H Health Investment, and 3W Partners, report zero disclosed funding, a pattern I'd call structural opacity rather than absence of activity.

So what's moving right now? Median install growth across fund-raising, venture capital and private equity apps is running at roughly +17% year-on-year across 37 tracked apps, a signal that retail and institutional appetite alike is climbing. Hot themes this quarter are stock performance, equity markets and currency ETFs, with Invesco currency products getting specific attention. Active investors like CoStone Capital and Ariane Capital are sustaining coverage breadth even as disclosed figures stay thin. Accessing top-tier PE funds is a conversation happening globally right now, and China's fragmented-but-active private equity scene sits right at the center of that question. If you're mapping this space, the concentration at the top and the depth below it are both worth your attention.